Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Author:

Tsuji Hideaki1,Nakashima Ran1ORCID,Hosono Yuji2,Imura Yoshitaka3,Yagita Masato3,Yoshifuji Hajime1,Hirata Shintaro4ORCID,Nojima Takaki4,Sugiyama Eiji4,Hatta Kazuhiro5,Taguchi Yoshio5,Katayama Masaki6ORCID,Tanizawa Kiminobu1,Handa Tomohiro1,Uozumi Ryuji1ORCID,Akizuki Shuji1,Murakami Kosaku1,Hashimoto Motomu1,Tanaka Masao1,Ohmura Koichiro1,Mimori Tsuneyo1

Affiliation:

1. Kyoto University Graduate School of Medicine Kyoto Japan

2. National Institute of Arthritis and Musculoskeletal and Skin DiseasesNIH Bethesda Maryland

3. Kitano Hospital Osaka Japan

4. Hiroshima University Hospital Hiroshima Japan

5. Tenri Hospital Tenri Japan

6. Osaka Red Cross Hospital Osaka Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3